Medication Safety Intensive
Three-times-a-year, for more than a decade, practitioners from the US and around the world attend the highly praised Medication Safety Intensive (MSI) workshop. Although the recent pandemic has brought a halt to our in-person meetings, we strongly believe in the value of shared learning for advancing medication safety. To that end, we are excited to announce our new Virtual MSI session, and NOW is the time to attend! As before, this unique two-day program will be led by ISMP faculty and is designed to help you enhance your effectiveness in meeting today’s medication safety challenges.
Whether you are a pharmacist or nurse leader, a physician or dedicated safety officer, from an inpatient facility, or an ambulatory setting, novice or experienced practice leader, our faculty will challenge you to see your organization through the eyes of leading safety experts, focusing targeted efforts on medication-related issues that impact patient safety. During this virtual program you will engage in group discussions, participate in hands-on practice in error analysis, evaluate latent and active failures related to medication errors, learn how to effectively select high-leverage strategies, identify risk before errors cause harm, and use data to help sustain safety efforts within your organization.
Upon completion of this workshop, you will be armed with a valuable understanding of the infrastructure needed to support continued safety improvements, while acquiring the specific knowledge, resources, and tools needed to be successful as a medication safety leader; ready to support a sustainable medication safety program.
Practitioners with responsibility for medication safety oversight including:
- Medication Safety and Patient Safety Officers/Managers
- Risk and Quality Improvement Professionals
- Directors of Pharmacy and Nursing
- Clinical Leads/Nurse Managers
- Chief Medical Officers
- Frontline clinical staff interested in medication safety
- Pharmacy Residents
Following completion of this workshop, participants will be able to:
- Perform system-based medication error analysis.
- Identify latent and active failures that lead to medication error events.
- Develop error-reduction strategies for the use of high-alert medications.
- Utilize various data collection methods to identify medication-related risk.
- Discuss the role and responsibilities of the medication safety officer or individual(s) responsible for medication safety oversight.
- Identify tools available to advance medication safety initiatives.
- Identify human error, at-risk behavior, and reckless behaviors from case studies and describe appropriate organizational responses to behavioral choices.
- Measure the effectiveness of selected error-reduction strategies.
- Network with other practitioners to problem solve challenging medication safety issues.
"The word 'intensive' truly defines the two days; I felt it translated into more than two years' worth of opportunities for growth and program development. The speakers' perspectives were founded in decades of practical experience but retained a forward-thinking mindset for innovation. This was a valuable and inspirational workshop."
-Jessica Kaczor, PharmD, BCPS
Upcoming Workshop Dates:
- December 3 & 4, 2020
Day 1- 8:00 am - 4:30 pm ET
Day 2- 8:00 am - 2:30 pm ET
Each workshop will feature speakers drawn from our distinguished faculty:
- Matthew Grissinger, RPh, FISMP, FASCP
Director, Error Reporting Programs
ISMP, Horsham, PA
- Liz Hess, PharmD, MS, FISMP
Pharmacy Program Coordinator, Medication Use Safety & Quality
Assistant Program Director, Medication Use Safety Pharmacy Residency
UK Healthcare, Lexington, KY
- Susan Paparella, MSN, RN
ISMP, Horsham, PA
- Judy Smetzer, BSN, RN, FISMP
ISMP, Horsham, PA
- Elizabeth Wade, PharmD, BCPS
Medication Safety Officer
Concord Hospital, Concord, NH
- Virtual Registration: $900.00 USD
Looking for mentorship time with ISMP? Contact us about the one-week Practitioner in Residence Mentorship program
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for up to 12.5 hours (1.25 CEUs) of continuing pharmacy education. Statement of credit will be emailed within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. This program has been assigned the Universal Program Number 0761-9999-19-130-L05-P, 0761-9999-19-130-L05-T. Educational Review Systems is also approved for pharmacy continuing education by the state of Florida. Nursing continuing education provider is approved by the California Board of Registered Nursing. This program has been assigned the Universal Program Number CEP 13677 and is approved for 12.5 contact hours (1.25 CEUs) of continuing nursing education.
All registration cancellations must be in writing to Nicole Powell at [email protected]. Cancellations received more than 72 hours in advance of program start date are refunded less a $100 administrative fee. No refunds are made for cancellations received less than 72 hours in advance of program start date. If you plan to send someone else in your place, please notify ISMP prior to the day of the program.
In the event that ISMP must change the date of the program and a registrant is no longer able to attend as a result of the change, ISMP will issue a refund in the amount of the registration fee.